There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Frustrated by past New Year's resolutions, columnist Desiree Lama is setting intentions to help redefine what progress with ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

The Cruel Intentions actress was first diagnosed with the autoimmune disease in 2018 and has been in remission since 2021.

The 54-year-old star recalled a phase when she had experienced MS flare-up, a moment she described that felt like her own ...